Key result
Transcatheter aortic valve implantation significantly reduced the prevalence of pulmonary hypertension from 51% at baseline to 29% at 6 months (p<.0001).
Why the study?
Elevated pulmonary artery pressure in severe aortic stenosis predicts adverse prognosis, but its determinants and drivers of change after TAVI required assessment.
Does transcatheter aortic valve implantation improve pulmonary artery pressure in elderly patients with symptomatic severe aortic stenosis?
Cohort (n=170)
Does transcatheter aortic valve implantation improve pulmonary artery pressure in elderly patients with symptomatic severe aortic stenosis?
In elderly patients with severe aortic stenosis undergoing TAVI, pulmonary hypertension significantly improves at 6 months, with the change in E/e' ratio being the primary independent predictor of PAP variation.
TAVI was associated with reduced pulmonary hypertension prevalence in severe aortic stenosis; hypothesis-generating for outcomes and requires randomized confirmation before practice change.
Background Elevated pulmonary artery pressure (PAP) in patients with severe aortic stenosis (AS) is a strong predictor of adverse prognosis. This study sought to assess the relation between PAP and clinical and echocardiographic parameters in elderly patients with severe AS, as well as to identify the determinants of the change in PAP after transcatheter aortic valve implantation (TAVI).Methods The study included 170 subjects (age 81 ± 7 years, 45% men) with symptomatic severe AS who were treated by TAVI. They underwent a clinical evaluation and a transthoracic echocardiography before the TAVI procedure and 6 months after.Results In a multivariable analysis, the independent predictors for baseline PAP were the body mass index (BMI) (β = 0.21, p = .006), COPD GOLD class (β = 0.20; p = .009), the E/e′ ratio (β = 0.20; p = .02) and the degree of aortic regurgitation (β = 0.20; p = .01). After TAVI, there was significantly less (51% vs. 29%, p<.0001) pulmonary hypertension, defined as a tricuspid regurgitation velocity ≥2.8 m/s. The baseline variables related to an improvement in PAP were the tricuspid regurgitation velocity (p = .0001) and the E/e′ (p = .005). From the parameters potentially modified with TAVI, the only independent predictor of PAP variation was the change in the E/e′ ratio (β = 0.23; p = .01).Conclusions Independent predictors for baseline PAP in elderly patients with symptomatic AS were the BMI, GOLD class, the aortic regurgitation and the E/e′ ratio. The baseline predictors for a change in PAP 6 months after TAVI were the baseline PAP and E/e′, with only the change in the E/e′ ratio being correlated to the change in PAP.
No takes yet. Share an insight, caveat, or question.
Strachinaru et al. (2020) conducted a cohort in symptomatic severe aortic stenosis (n=170). Transcatheter aortic valve implantation (TAVI) vs. Baseline was evaluated on Pulmonary hypertension (tricuspid regurgitation velocity ≥2.8 m/s) (p=<.0001). Transcatheter aortic valve implantation significantly reduced the prevalence of pulmonary hypertension from 51% at baseline to 29% at 6 months (p<.0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More on TAVR in low-risk patientsMore from Acta cardiologica. Supplementum